article information

Nephro-Urology Monthly: Vol.7, issue 6; e31967
published online: November 29, 2015
article type: Research Article
received: July 30, 2015
revised: September 4, 2015
accepted: September 16, 2015
DOI: https://doi.org/10.5812/numonthly.31967
Crossmark

Restless Legs Syndrome: Associated Risk Factors in Hemodialysis Patients

authors:

avatar Seyed Seifollah Beladi-Mousavi 1 , avatar Mehrian Jafarizade 1 , avatar Shokouh Shayanpour 1 , avatar Mohammad Bahadoram 1 , 2 , avatar Seyed Mostafa Moosavian 1 , 2 , * , avatar Gholamreza Houshmand 3

Chronic Renal Failure Research Center, Department of Internal Medicine, Faculty of Medicine, Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Medical Student Research Committee, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Department of Pharmacology and Toxicology, Herbal Research Center, Pharmacy School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran

how to cite: Beladi-Mousavi S S, Jafarizade M, Shayanpour S, Bahadoram M, Moosavian S M, et al. Restless Legs Syndrome: Associated Risk Factors in Hemodialysis Patients. Nephro-Urol Mon. 2015;7(6):e31967. https://doi.org/10.5812/numonthly.31967.

Abstract

Background:

Restless legs syndrome (RLS) may be associated with increased morbidity and mortality among end-stage renal disease (ESRD) patients; however, it is a disorder that is neglected in dialysis centers.

Objectives:

The goal of this study was to investigate the clinical factors associated with RLS among ESRD patients.

Patients and Methods:

This cross-sectional study was conducted on ESRD patients undergoing maintenance hemodialysis (HD) in three HD centers in Ahvaz city in Southwest Iran. Blood samples were obtained prior to a dialysis session to check the routine laboratory test results and assess the adequacy of dialysis. The presence of RLS was assessed by using the international RLS study group (IRLSSG) diagnostic criteria. The IRLSSG rating scale was also used to evaluate the severity of the RLS symptoms.

Results:

Of the 139 HD patients enrolled in this study, 60 were female (43.2%) and 79 were male (56.8%), with a mean age of 51.82 ± 13.31 years. The prevalence of RLS was 15.8% (22 patients), with 50% of them (11 patients) having severe or very severe symptoms. There was a significant relationship between RLS and longer durations of dialysis (P < 0.001). The mean level of serum ferritin was lower in patients without RLS, but it was not significant (P = 0.065). No significant differences were found according to age, gender, dialysis shifts, and hemoglobin (Hb) level among patients with and without RLS.

Conclusions:

We conclude that a significant percentage of ESRD patients undergoing maintenance HD have severe or very severe RLS symptoms. The presence of RLS is associated to longer durations of dialysis.

1. Background

Restless legs syndrome (RLS) is a sensorimotor disorder characterized by an unpleasant sensation in the legs and, consequently, the patients’ urge to move the lower extremities (1). These symptoms usually emerge at night or at times of rest, leading to sleep disturbances (2, 3), which are relieved by movement (4).

The prevalence of RLS in the general population varies widely depending upon the population surveyed. For example, it is reported that the prevalence of RLS in Europe and North America is 5 - 20% and in Asia less than 4% (5-7).

RLS occurs in both men and women at any age; however, it seems that the incidence of RLS is approximately twice as high in women. Several studies have shown that the symptoms typically become more frequent and last longer with age, from 3% of participants aged 18 to 29, 10% for those aged 30 to 79, and up to 19% for those aged 80 or older. In most people with moderate to severe RLS, the condition causes exhaustion, daytime fatigue, and depression, and activities of daily living are strongly affected as a result of the condition (1, 2, 4).

In most cases, RLS is a primary idiopathic disorder with unknown causes, but it can also be associated with a number of medical disorders, including diabetes mellitus, iron deficiency, multiple sclerosis, Parkinson’s disease, rheumatic disease, and venous insufficiency (8-11).

End-stage renal disease (ESRD), which is defined as an irreversible and advanced loss of renal function requiring renal replacement therapy, appears to be another risk factor for the occurrence or worsening of RLS (12-15). It is also suggested that RLS may be associated with increased morbidity and mortality among ESRD patients (16-18). However, it seems that the importance of RLS and its treatment are neglected issues in dialysis centers (19).

The mechanism of increased mortality among ESRD patients is not well understood, but it may be due to poor compliance with therapy, impaired health-related quality of life, depression, and the psychological consequences of recurrent sleep disruption in these patients (19).

Although many studies about the epidemiology, causes, and treatment of primary RLS in the general population have been conducted, researches about secondary RLS, especially among patients with ESRD which is a life-threatening disease with significant complications, are limited and give conflicting results (12-15, 20, 21); therefore, further studies about these patients are needed.

2. Objectives

The goal of this study was to investigate the frequency of RLS among patients with ESRD undergoing maintenance hemodialysis in Khuzestan, Iran, and to evaluate its relationship with hemoglobin (Hb), ferritin, calcium, phosphate levels, disease duration, and the Kt/V index among these patients.

3. Patients and Methods

3.1. Study Subjects

All ESRD patients under regular hemodialysis at three dialysis centers in the Ahvaz Jundishapur university hospitals between April 2011 and January 2013 were included in this study. Patients were included if they had undergone regular hemodialysis and their Glasgow coma scale score was equal to 15. The protocol was approved by the ethics committee of the chronic renal failure research center’s Ahvaz Jundishapur university of medical sciences. The aim of the study was explained to the participants and written informed consents were obtained. It was decided to exclude patients with less than three months’ dialysis treatment, patients with severe infections, and patients who refused to participate or who were unable to communicate before the study commenced.

3.2. Study Design

Of the 180 HD patients enrolled in the study, 41 were excluded. Twenty patients refused to participate, 11 patients had less than three months of dialysis treatment, five patients could not speak the Persian language, and five patients were excluded because of psychiatric disorders. The demographic information of ESRD patients, such as age, gender, weeks on dialysis, and shift of HD, was assessed by reviewing the patients’ files.

Blood samples were obtained from patients who participated in the study prior to a dialysis session to check the routine laboratory test results, including calcium, phosphorus, Hb, serum ferritin, and alkaline phosphatase. In addition, to assess the adequacy of dialysis, blood urea nitrogen (BUN) before and after hemodialysis and ultrafiltration rate were also measured, and according to these parameters, the urea reduction ratio (URR) and Kt/V were calculated.

The presence of RLS was assessed by using the international RLS study group (IRLSSG) diagnostic criteria, and these questionnaires were conducted through face-to-face interviews by one of the investigators (22, 23) (Box 1). Four questions proposed by the IRLSSG for diagnosing RLS were used. Patients who answered “yes” to all four of these essential questions were classified as “RLS positive” and were asked to answer 10 questions on the IRLSSG rating scale (22, 24). The IRLSSG rating scale was also used to evaluate the severity of RLS symptoms.

Box 1.

Essential Diagnostic Criteria for RLS

Criteria
1. An irresistible urge to move the legs, usually accompanied by an unpleasant sensation in the legs (these symptoms are described as creeping, crawling, tingling, aching, burning, itching, or cramping).
2. The urge to move or unpleasant sensations beginning or worsening during periods of rest or inactivity such as lying or sitting.
3. The urge to move or unpleasant sensations are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues.
4. The urge to move or unpleasant sensations are worse in the evening or night than during the day or only occur in the evening or night.

3.3. Hemodialysis Methods

All subjects received hemodialysis by Fresenius machines in three four-hour shifts, with the morning shift starting at 8 AM, the afternoon shift starting at 3 PM, and the evening shift starting at 8 PM. Regular hemodialysis is defined as hemodialysis three or four times a week for at least three months by using semi-synthetic (cellulose diacetate) or synthetic (polysulfone) dialysis membranes and bicarbonate buffered dialysate. The rate of blood flow was maintained at 250 - 400 mL/minute and the dialysate flow rate was 500 mL/minute.

3.4. Statistical Analysis

The chi-square test was used for the categorical variables and the t-test was used for continuous variables. The continuous data are presented as mean ± standard deviation. A P Value < 0.05 was considered statistically significant. In a forward manner, multivariate logistic regression analysis was used to evaluate factors independently predicting the presence of RLS. Odds ratio (OR) and 95% confidence interval (CI) were also calculated. All analyses were performed using SPSS version 17 software.

4. Results

Data from 139 patients were analyzed. The mean age was 51.82 ± 13.31 years and there were 60 females (43.2%) and 79 males (56.8%). The mean duration of the patients’ dialysis was 126.24 ± 120.542 weeks. RLS was found in 15.8% of the patients in this study. According to the IRLSSG rating scale (22), symptom severity in the RLS group was mild in three patients (13.63%), moderate in eight patients (36.36%), severe in nine patients (40.9%), and very severe in two patients (9.09%). The demographic and biochemical characteristics of the patients with and without RLS is compared in Table 1. Compared to patients with RLS, the mean level of ferritin was lower in patients without RLS, but this difference was not statistically significant (P Value = 0.065).

The duration of dialysis was significantly longer among patients with RLS compared to patients without RLS (P Value < 0.001). The duration of dialysis was defined as the number of weeks in which the patients had been under continuous dialysis.

No significant associations were found between RLS and age, gender, dialysis shift, and levels of Hb, calcium, phosphate, URR, and Kt/v (P Value > 0.05). We built multivariate logistic regression models with the presence of RLS as the dependent variable and several covariables, such as age, gender, duration of dialysis, and levels of calcium, phosphate, Hb, ferritin, URR, and Kt/V as independent variables. The regression analysis revealed that a longer duration of dialysis was the only independent factor associated with the presence of RLS while controlling for other variables (OR = 1.006, 95% CI = 1.002 - 1.009, P Value = 0.001).

Table 1.

Demographic and Laboratory Variables Between ESRD Patients with RLS and Without RLSa

Demographic and Laboratory DataAll Patients (n = 139)RLS (n = 22)No RLS (n = 117)P Value
Age, y b51.82 ± 13.31651.91 ± 13.57551.80 ± 13.326.973
Gender.492
Female601149
Male791168
Weeks on dialysis b126.24 ± 120.542211.45 ± 151.736110.22 ± 107.154< .001
Shift of dialysis .959
Morning721260
Afternoon53845
Evening14212
Hb, g/dL b10.235 ± 1.86610.324 ± 1.59610.219 ± 1.916.814
Calcium, mg/dL b8.43 ± 1.4038.543 ± 1.1798.409 ± 1.4438.690
Phosphate, mg/dL b5.634 ± 1.7955.567 ± 1.5925.646 ± 1.835.853
Ferritin, ng/mL b602.167 ± 265.485713.000 ± 211.812578.203 ± 270.993.065
Kt/V b1.24 ± 0.031.25 ± 0.031.24 ± 0.04.613
URR, % b66.02 ± 0.866.32 ± 1.165.97 ± 0.82.087

aP < 0.05 was considered a statistically significant difference.

bValues are presented as mean ± SD.

Abbreviations: Hb, Hemoglobin; Kt/V is a number used to quantify hemodialysis (K, dialyzer clearance of urea; t, dialysis time; V, volume of distribution of urea, approximately equal to patient’s total body water); URR, urea reduction ratio.

5. Discussion

The prevalence of RLS among our HD patients was 15.8%, with 50% of them having severe or very severe symptoms, which can have a great influence on their quality of life. The frequency of RLS in our study differs from the results of previous studies on ESRD populations in other countries. For example, the prevalence of RLS among ESRD patients in Korea is 28%, Japan 23%, and in India 6.6%, respectively (4, 25, 26). These variations of RLS prevalence across different populations might be due to racial differences, language, culture, and the genetics of the studied populations, small study samples, environmental factors, as well as different understandings of common diagnostic criteria (4).

Furthermore, previous studies on the Iranian ESRD population have reported different RLS prevalence, for example, 8% (27) and 32% (28). These variations suggest differences in inclusion and exclusion criteria of the studies or in study strategies for using the IRLSSG criteria to diagnose RLS (i.e. face-to-face interviews or self-administrated questionnaires), different sample sizes in the studies, or different population study characteristics such as mean age, female gender percentile, mean dialysis duration, dialysis strategies, the number of centers included in the study and different biochemical markers (24).

The pathogenesis of RLS among patients with ESRD is not understood. However, it is reported that some factors, including anemia, iron deficiency and elevated serum calcium, may predispose ESRD patients to develop RLS. In addition, central nervous system abnormalities and peripheral neuropathy, secondary to uremia or the underlying cause of ESRD (such as diabetes), may also contribute. The relationship between iron deficiency and ESRD-associated RLS has been suggested by some studies. Iron deficiency in ESRD patients may lead to RLS due to some possible underlying mechanisms, including anemia and alterations of dopamine metabolism in the central nervous system.

Although in our study, the ferritin level tended to be elevated among patients with RLS, this was not statistically significant, nor was it in other studies (4, 12, 14, 26, 29-33).

The serum ferritin level is not a good predictor for iron status among ESRD patients because it is also a positive acute phase reactant protein (34).

In our study, a significant relationship was found between the duration of dialysis and the presence of RLS. This close relationship suggests that the duration of dialysis may be a risk factor for developing RLS. Similar to our study, a few studies have found a relationship between dialysis duration and the presence of RLS (35-37), but this finding has not been confirmed by other studies (4, 38-40)

We found no association between the presence of RLS and the mean age of ESRD patients, similar to the results of previous studies (12, 31, 32, 41), although some studies have conflicting results (4, 26).

In contrast to the results of our study, some investigations have shown that RLS is more prevalent in uremic females (12, 31). For example, Manna et al. reported that RLS is significantly associated with the female gender (31). Berger et al. also reported that the incidence of RLS is approximately 10 times greater among women in the general population. No significant difference was found between the prevalence of RLS in young nulliparous women and men in Berger et al.’s study; therefore, they proposed parity as a major risk factor for RLS and suggested the role of excess estrogen in women (42). However, similar to our results, some studies have not found gender differences between patients with and without RLS (2, 4, 25, 33).

The results of our research are limited by the short duration and small number of patients enrolled in the study; therefore, multicenter clinical trials with longer durations and larger numbers of patients are needed to determine the frequency of RLS and its relationship with ESRD among patients undergoing maintenance hemodialysis.

Restless legs syndrome (RLS) is a sensorimotor disorder which causes exhaustion, sleep disturbances, daytime fatigue, and depression among most people with moderate to severe diseases. On the other hand, ESRD appears to be a risk factor for the occurrence or worsening of RLS, and it may be associated with increased morbidity and mortality among these patients. It is reported that anemia, iron deficiency, elevated serum calcium, central nervous system abnormalities, and peripheral neuropathy secondary to uremia or the underlying cause of ESRD (such as diabetes) may predispose ESRD patients to developing RLS. According to the results of our study, a significant percentage of patients with ESRD undergoing maintenance HD have severe or very severe symptoms of RLS, and it is strongly related to increased durations of dialysis. Therefore, this disease should not be neglected or unrecognized by renal healthcare providers. Although many studies have been performed to identify the risk factors of RLS among uremic patients, the results are conflicting and, therefore, more comprehensive randomized clinical trials are needed in future.

Acknowledgements

References

  • 1.

    Perl J, Unruh ML, Chan CT. Sleep disorders in end-stage renal disease: 'Markers of inadequate dialysis'? Kidney Int. 2006;70(10):1687-93. [PubMed ID: 16969388]. https://doi.org/10.1038/sj.ki.5001791.

  • 2.

    Aritake-Okada S, Nakao T, Komada Y, Asaoka S, Sakuta K, Esaki S, et al. Prevalence and clinical characteristics of restless legs syndrome in chronic kidney disease patients. Sleep Med. 2011;12(10):1031-3. [PubMed ID: 22036105]. https://doi.org/10.1016/j.sleep.2011.06.014.

  • 3.

    Chavoshi F, Einollahi B, Sadeghniat Haghighi K, Saraei M, Izadianmehr N. Prevalence and sleep related disorders of restless leg syndrome in hemodialysis patients. Nephrourol Mon. 2015;7(2). eee24611. [PubMed ID: 25883911]. https://doi.org/10.5812/numonthly.24611.

  • 4.

    Kim JM, Kwon HM, Lim CS, Kim YS, Lee SJ, Nam H. Restless legs syndrome in patients on hemodialysis: symptom severity and risk factors. J Clin Neurol. 2008;4(4):153-7. [PubMed ID: 19513290]. https://doi.org/10.3988/jcn.2008.4.4.153.

  • 5.

    Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev. 2006;10(3):153-67. [PubMed ID: 16762806]. https://doi.org/10.1016/j.smrv.2006.01.001.

  • 6.

    Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002;53(1):547-54. [PubMed ID: 12127170].

  • 7.

    Sevim S, Dogu O, Camdeviren H, Bugdayci R, Sasmaz T, Kaleagasi H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology. 2003;61(11):1562-9. [PubMed ID: 14663043].

  • 8.

    Hassan N, Pineau CA, Clarke AE, Vinet E, Ng R, Bernatsky S. Systemic lupus and risk of restless legs syndrome. J Rheumatol. 2011;38(5):874-6. [PubMed ID: 21324968]. https://doi.org/10.3899/jrheum.101039.

  • 9.

    Li Y, Munger KL, Batool-Anwar S, De Vito K, Ascherio A, Gao X. Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women. Neurology. 2012;78(19):1500-6. [PubMed ID: 22539566]. https://doi.org/10.1212/WNL.0b013e3182553c5b.

  • 10.

    Merlino G, Fratticci L, Valente M, Del Giudice A, Noacco C, Dolso P, et al. Association of restless legs syndrome in type 2 diabetes: a case-control study. Sleep. 2007;30(7):866-71. [PubMed ID: 17682657].

  • 11.

    Silber MH, Richardson JW. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc. 2003;78(1):52-4. [PubMed ID: 12528877]. https://doi.org/10.4065/78.1.52.

  • 12.

    Araujo SM, de Bruin VM, Nepomuceno LA, Maximo ML, Daher Ede F, Correia Ferrer DP, et al. Restless legs syndrome in end-stage renal disease: Clinical characteristics and associated comorbidities. Sleep Med. 2010;11(8):785-90. [PubMed ID: 20667773]. https://doi.org/10.1016/j.sleep.2010.02.011.

  • 13.

    Salman SM. Restless legs syndrome in patients on hemodialysis. Saudi J Kidney Dis Transpl. 2011;22(2):368-72. [PubMed ID: 21422649].

  • 14.

    Tuncel D, Orhan FO, Sayarlioglu H, Isik IO, Utku U, Dinc A. Restless legs syndrome in hemodialysis patients: association with depression and quality of life. Sleep Breath. 2011;15(3):311-5. [PubMed ID: 20593280]. https://doi.org/10.1007/s11325-010-0382-z.

  • 15.

    Takaki J, Nishi T, Nangaku M, Shimoyama H, Inada T, Matsuyama N, et al. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis. 2003;41(4):833-9. [PubMed ID: 12666070].

  • 16.

    Beladi-Mousavi SS, Alemzadeh-Ansari MJ, Alemzadeh-Ansari MH, Beladi-Mousavi M. Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran. Iran J Kidney Dis. 2012;6(6):452-6. [PubMed ID: 23146984].

  • 17.

    Jung HH, Lee JH, Baek HJ, Kim SJ, Lee JJ. Nocturnal hypoxemia and periodic limb movement predict mortality in patients on maintenance hemodialysis. Clin J Am Soc Nephrol. 2010;5(9):1607-13. [PubMed ID: 20507958]. https://doi.org/10.2215/CJN.08881209.

  • 18.

    Molnar MZ, Szentkiralyi A, Lindner A, Czira ME, Szeifert L, Kovacs AZ, et al. Restless legs syndrome and mortality in kidney transplant recipients. Am J Kidney Dis. 2007;50(5):813-20. [PubMed ID: 17954294]. https://doi.org/10.1053/j.ajkd.2007.08.003.

  • 19.

    Walters AS, Rye DB. Evidence continues to mount on the relationship of restless legs syndrome/ periodic limb movements in sleep to hypertension, cardiovascular disease, and stroke. Sleep. 2010;33(3):287. [PubMed ID: 20337185].

  • 20.

    Beladi-Mousavi SS, Alemzadeh-Ansari MJ, Cheraghian B. Outcome of patients on haemodialysis in Khuzestan, Iran. NDT plus. 2011;4(2):143.

  • 21.

    Beladi Mousavi SS, Sametzadeh M, Hayati F, Fatemi SM. Evaluation of acquired cystic kidney disease in patients on hemodialysis with ultrasonography. Iran J Kidney Dis. 2010;4(3):223-6. [PubMed ID: 20622311].

  • 22.

    Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121-32. [PubMed ID: 14592342].

  • 23.

    Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord. 1995;10(5):634-42. [PubMed ID: 8552117]. https://doi.org/10.1002/mds.870100517.

  • 24.

    Einollahi B, Izadianmehr N. Restless leg syndrome: a neglected diagnosis. Nephrourol Mon. 2014;6(5). eee22009. [PubMed ID: 25695039]. https://doi.org/10.5812/numonthly.22009.

  • 25.

    Bhowmik D, Bhatia M, Gupta S, Agarwal SK, Tiwari SC, Dash SC. Restless legs syndrome in hemodialysis patients in India: a case controlled study. Sleep Med. 2003;4(2):143-6. [PubMed ID: 14592345].

  • 26.

    Kawauchi A, Inoue Y, Hashimoto T, Tachibana N, Shirakawa S, Mizutani Y, et al. Restless legs syndrome in hemodialysis patients: health-related quality of life and laboratory data analysis. Clin Nephrol. 2006;66(6):440-6. [PubMed ID: 17176916].

  • 27.

    Malaki M, Mortazavi FS, Moazemi S, Shoaran M. Insomnia and limb pain in hemodialysis patients: what is the share of restless leg syndrome? Saudi J Kidney Dis Transpl. 2012;23(1):15-20. [PubMed ID: 22237212].

  • 28.

    Razeghi E, Sahraian MA, Heidari R, Bagherzadeh M. Association of inflammatory biomarkers with sleep disorders in hemodialysis patients. Acta Neurol Belg. 2012;112(1):45-9. [PubMed ID: 22427289]. https://doi.org/10.1007/s13760-012-0003-7.

  • 29.

    Al-Jahdali HH, Al-Qadhi WA, Khogeer HA, Al-Hejaili FF, Al-Ghamdi SM, Al Sayyari AA. Restless legs syndrome in patients on dialysis. Saudi J Kidney Dis Transpl. 2009;20(3):378-85. [PubMed ID: 19414938].

  • 30.

    Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand GF, Oertel WH, Trenkwalder C. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis. 1998;31(2):324-8. [PubMed ID: 9469505].

  • 31.

    La Manna G, Pizza F, Persici E, Baraldi O, Comai G, Cappuccilli ML, et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transplant. 2011;26(6):1976-83. [PubMed ID: 21056943]. https://doi.org/10.1093/ndt/gfq681.

  • 32.

    Mucsi I, Molnar MZ, Ambrus C, Szeifert L, Kovacs AZ, Zoller R, et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant. 2005;20(3):571-7. [PubMed ID: 15671074]. https://doi.org/10.1093/ndt/gfh654.

  • 33.

    Soyoral Y, Sayarlioglu H, Tuncel D, SAHİN M, Dogan E, Erkoc R. Prevalence and risk factors of restless leg syndrome in a single hemodialysis unit. Turk J Med Sci. 2010;40(3):443-6.

  • 34.

    Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis. 2004;43(4):663-70. [PubMed ID: 15042543].

  • 35.

    Gigli GL, Adorati M, Dolso P, Piani A, Valente M, Brotini S, et al. Restless legs syndrome in end-stage renal disease. Sleep Med. 2004;5(3):309-15. [PubMed ID: 15165541]. https://doi.org/10.1016/j.sleep.2004.01.014.

  • 36.

    Roger SD, Harris DC, Stewart JH. Possible relation between restless legs and anaemia in renal dialysis patients. Lancet. 1991;337(8756):1551. [PubMed ID: 1675404].

  • 37.

    Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis. 1996;28(3):372-8. [PubMed ID: 8804235].

  • 38.

    Bastos JP, Sousa RB, Nepomuceno LA, Gutierrez-Adrianzen OA, Bruin PF, Araujo ML, et al. Sleep disturbances in patients on maintenance hemodialysis: role of dialysis shift. Rev Assoc Med Bras. 2007;53(6):492-6. [PubMed ID: 18157361].

  • 39.

    Huiqi Q, Shan L, Mingcai Q. Restless legs syndrome (RLS) in uremic patients is related to the frequency of hemodialysis sessions. Nephron. 2000;86(4):540. [PubMed ID: 11124621]. https://doi.org/10.1159/000045861.

  • 40.

    Miranda M, Araya F, Castillo JL, Duran C, Gonzalez F, Aris L. [Restless legs syndrome: a clinical study in adult general population and in uremic patients]. Rev Med Chil. 2001;129(2):179-86. [PubMed ID: 11351470].

  • 41.

    Goffredo Filho GS, Gorini CC, Purysko AS, Silva HC, Elias IE. Restless legs syndrome in patients on chronic hemodialysis in a Brazilian city: frequency, biochemical findings and comorbidities. Arq Neuropsiquiatr. 2003;61(3b):723-7. [PubMed ID: 14595472].

  • 42.

    Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164(2):196-202. [PubMed ID: 14744844]. https://doi.org/10.1001/archinte.164.2.196.